Work

Cost-effectiveness analysis in the era of systemic immunotherapy for BCG-naive high-risk non–muscle-invasive bladder cancer in the United States, the United Kingdom, and China.

Year: 2026

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2026.44.16_suppl.4598

Authors: Zihan Xue, Yunkai Qie, Xiaohua Li, Shan Liang, Jiazeng Zhao, Liliang Li, Houyuan Chen, Yuda Lin, Guoqiang Han, Chong Shen, Zhouliang Wu, Hailong Hu

Institutions: Second Hospital of Tianjin Medical University, Daqing Oilfield General Hospital

Language: English

Topic: Bladder and Urothelial Cancer Treatments

Subfield: Surgery

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7162523372

Cites:

Cited by:

Related to: